Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Camillo Ribi

Showing results (111-120 of 124) with videos related to

Pageof 13
Sort By:
Swiss Medical Weekly|August 14, 2014
The Swiss Systemic lupus erythematosus Cohort Study (SSCS) - cross-sectional analysis of clinical characteristics and treatments across different medical disciplines in SwitzerlandCamillo Ribi, Marten Trendelenburg, Angèle Gayet-Ageron, et al.
Swiss Medical Weekly|April 5, 2024
Therapeutic management of fibrosis in systemic sclerosis patients - an analysis from the Swiss EUSTAR cohortKevin Windirsch, Suzana Jordan, Mike Oliver Becker, et al.
Nature Reviews. Clinical Oncology|May 17, 2019
Adverse effects of immune-checkpoint inhibitors: epidemiology, management and surveillanceFilipe Martins, Latifyan Sofiya, Gerasimos P Sykiotis, et al.
Presse Medicale (Paris, France : 1983)|July 10, 2020
ANCA-associated vasculitides: Recommendations of the French Vasculitis Study Group on the use of immunosuppressants and biotherapies for remission induction and maintenanceBenjamin Terrier, Pierre Charles, Olivier Aumaître, et al.
JAMA Oncology|March 10, 2022
Humoral Responses Against Variants of Concern by COVID-19 mRNA Vaccines in Immunocompromised PatientsMichel Obeid, Madeleine Suffiotti, Celine Pellaton, et al.
Swiss Medical Weekly|April 3, 2023
Management of giant-cell arteritis in Switzerland: an online national surveyMichele Iudici, Andrea Katharina Hemmig, Mihaela Stegert, et al.
Swiss Medical Weekly|January 24, 2022
Sarcoidosis - a multisystem diseaseDaniel P Franzen, Martin Brutsche, Jakob Nilsson, et al.
Frontiers in Cardiovascular Medicine|August 7, 2023
Case report: First-in-human combined low-dose whole-heart irradiation and high-dose stereotactic arrhythmia radioablation for immunosuppressive refractory cardiac sarcoidosis and ventricular tachycardiaMartijn H van der Ree, Claudia Herrera Siklody, Mathieu Le Bloa, et al.
JAMA Dermatology|June 28, 2023
Cutaneous Manifestations, Clinical Characteristics, and Prognosis of Patients With Systemic Sclerosis Sine Scleroderma: Data From the International EUSTAR DatabaseAlain Lescoat, Suiyuan Huang, Patricia E Carreira, et al.
Rheumatology (Oxford, England)|March 29, 2022
Phenotype of limited cutaneous systemic sclerosis patients with positive anti-topoisomerase I antibodies: data from the EUSTAR cohortElisabetta Zanatta, Dörte Huscher, Augusta Ortolan, et al.
Pageof 13

Showing results (111-120 of 124) with videos related to

Sort By:
Pageof 13
Swiss Medical Weekly|August 14, 2014
The Swiss Systemic lupus erythematosus Cohort Study (SSCS) - cross-sectional analysis of clinical characteristics and treatments across different medical disciplines in SwitzerlandCamillo Ribi, Marten Trendelenburg, Angèle Gayet-Ageron, et al.
Swiss Medical Weekly|April 5, 2024
Therapeutic management of fibrosis in systemic sclerosis patients - an analysis from the Swiss EUSTAR cohortKevin Windirsch, Suzana Jordan, Mike Oliver Becker, et al.
Nature Reviews. Clinical Oncology|May 17, 2019
Adverse effects of immune-checkpoint inhibitors: epidemiology, management and surveillanceFilipe Martins, Latifyan Sofiya, Gerasimos P Sykiotis, et al.
Presse Medicale (Paris, France : 1983)|July 10, 2020
ANCA-associated vasculitides: Recommendations of the French Vasculitis Study Group on the use of immunosuppressants and biotherapies for remission induction and maintenanceBenjamin Terrier, Pierre Charles, Olivier Aumaître, et al.
JAMA Oncology|March 10, 2022
Humoral Responses Against Variants of Concern by COVID-19 mRNA Vaccines in Immunocompromised PatientsMichel Obeid, Madeleine Suffiotti, Celine Pellaton, et al.
Swiss Medical Weekly|April 3, 2023
Management of giant-cell arteritis in Switzerland: an online national surveyMichele Iudici, Andrea Katharina Hemmig, Mihaela Stegert, et al.
Swiss Medical Weekly|January 24, 2022
Sarcoidosis - a multisystem diseaseDaniel P Franzen, Martin Brutsche, Jakob Nilsson, et al.
Frontiers in Cardiovascular Medicine|August 7, 2023
Case report: First-in-human combined low-dose whole-heart irradiation and high-dose stereotactic arrhythmia radioablation for immunosuppressive refractory cardiac sarcoidosis and ventricular tachycardiaMartijn H van der Ree, Claudia Herrera Siklody, Mathieu Le Bloa, et al.
JAMA Dermatology|June 28, 2023
Cutaneous Manifestations, Clinical Characteristics, and Prognosis of Patients With Systemic Sclerosis Sine Scleroderma: Data From the International EUSTAR DatabaseAlain Lescoat, Suiyuan Huang, Patricia E Carreira, et al.
Rheumatology (Oxford, England)|March 29, 2022
Phenotype of limited cutaneous systemic sclerosis patients with positive anti-topoisomerase I antibodies: data from the EUSTAR cohortElisabetta Zanatta, Dörte Huscher, Augusta Ortolan, et al.
Pageof 13